Account of the American Society of Clinical Oncology & its affiliate the Association for Clinical Oncology. Assoc tweets labeled #ASCOAdvocacy. RTs ≠ endorse.
Joined February 2009
- Tweets 41,777
- Following 2,370
- Followers 151,057
- Likes 39,625
4,792 Photos and videos
Our new position statement outlines ways to expand eligibility, increase funding & expand community access for pediatric oncology clinical trials.
Learn more: bit.ly/4v1q7J7
#ASCOAdvocacy
1
7
21
1,824
Dr. @oncology_bg reflects on the meaningful impact the 2026 ASCO-AIOM International Clinical Research Course had on its attendees from across the globe.
Learn more: bit.ly/4vAQN3s
#ASCOConnection
4
11
1,486
The treatment landscape for EGFR-mutant NSCLC has entered an exciting but complex era. For #ASCODailyNews, @guicorreiamd, @VamsiVelcheti, and Varun Elete discuss 3 valuable first-line approaches and the use of #ctDNA clearance to adapt therapy: bit.ly/43w4DYV
1
4
4
2,133
ASCO retweeted
Jun 10
🚀 Applications are NOW OPEN for the 2027-28 ASCO Leadership Development Program: Asia Pacific!
As an alumnus, this program was genuinely transformative — rigorous leadership training, deep regional networks, lasting friendships and trusted collaborations that continue today.
For mid-career oncology physicians across AP ready to grow: don’t miss this opportunity!
📅 Deadline: 17 Aug 2026 (11:59 PM ET)
🔗 Apply: asco.smapply.org/prog/2027-2…
Pass it on to colleagues who should apply!
#ASCO #LDP #AsiaPacific #OncologyLeadership @ASCO
2
6
12
2,171
There is a global surge in young-onset cancers, particularly within Asia Pacific. @KimmieNgMD is looking forward to #ASCOBT26 to discuss why understanding these epidemiologic trends is more urgent than ever.
Register today: bit.ly/4uneRps
5
13
2,017
👏Big news! The #SeniorsAct now has 290 cosponsors, a key milestone. Momentum is building for bipartisan reforms to #FixPriorAuth & improve pt care. Congress needs to act NOW. Tell Congress to pass the Seniors Act. bit.ly/4e1Yf1x
#ASCOAdvocacy
Jun 10
🚨NEWS: This week, my legislation, the "Improving Seniors' Timely Access to Care Act," reached 290 co-sponsors in the U.S. House -- an overwhelming bipartisan supermajority.
This legislation puts patient care and patient outcomes first, and it will greatly modernize and streamline the prior authorization process.
Learn more⬇️
kelly.house.gov/media/press-…
1
9
19
3,706
Thank you @SenHydeSmith for your Senate floor speech on the harms of prior auth. We appreciate your support of the ASCO-endorsed Seniors’ Act and Safe Step Act to reduce utilization management burdens to get care to patients faster. #FixPriorAuth #ASCOAdvocacy
Patients across the country are waiting days, weeks, or even months for care their doctor already prescribed. And too often, it’s still denied.
Today, I urged the Senate to pass bipartisan legislation to stop insurance companies from standing between patients and the care they need.
More details: hydesmith.senate.gov/hyde-sm…
4
5
23
2,926
Researching pediatric brain tumors? There's still time to apply for the @conquercancerFD Young Investigator Award. One year. $50k. Mentored research.
Learn more and apply by July 15: bit.ly/4ohzrWL
#CancerResearch
3
10
2,175
Propel your career forward by submitting your research on topics ranging from Cost, Value & Policy to Tech. Innovation in Quality Care to #ASCOQLTY26 in Boston. Let’s advance quality cancer care together. Submit an abstract by June 16 at 11:59 PM (ET): bit.ly/3SakHgn
8
8
1,827
#ASCOAdvocacy thanks the House Appropriations Committee for prioritizing cancer research as it considers the FY27 LHHS spending bill & urges robust funding to keep pace with scientific discovery & fully support the nation's research infrastructure. More: bit.ly/3SvBVVy
6
15
1,636
The draft living guideline protocol for "Systemic Therapy and Biomarker Testing for HR-Positive, Non-HER2-Overexpressing Metastatic Breast Cancer" is now available. Help us refine these standards of care. Submit your feedback by June 22!
Learn more: bit.ly/4e4BmcA
8
8
2,085
ASCO retweeted
Excited to participate in @ASCO Leadership Dev Prog (LDP) and learn from this exceptional cohort of participants and mentors
1
2
10
2,710
ASCO Breakthrough has been gaining momentum since its inception in Thailand back in 2019. Hear from Dr. @TonyMok9 on how this vital conference has evolved and what's in store for #ASCOBT26 in Singapore.
Register today: bit.ly/3ROvRay
1
8
1,855
ICYMI at #ASCO26: GLP-1 RAs are associated with reduced metastatic progression of 4 different malignancies and improved OS in 7 tumor types, per the results of a real-world analysis of 10,000 patients with cancer. #ASCODailyNews has more: bit.ly/43dQ3VK
3
7
11
2,459
The draft guideline recommendations for "Initial Treatment for Chronic Lymphocytic Leukemia" are now available. Help us refine these standards of care. Submit your feedback by June 15!
Read & comment: bit.ly/43EPFQa
#CLL
1
1
1,424
How do we integrate groundbreaking cancer innovations while ensuring they remain accessible? Join @oncology_bg at #ASCOBT26 as he explores critical solutions for cancer care in the Asia-Pacific region.
Register today: bit.ly/4uMWnQ4
1
4
14
6,500
The draft guideline recommendations for "Prehabilitation for People with Cancer" are now available. Help us refine these standards of care. Submit your feedback by June 15!
Read & comment: bit.ly/43EPFQa
1
7
9
2,070
Guideline Update: Stage IV #NSCLC ➡️ New data confirms PD-(L)1 monotherapy (atezolizumab, pembrolizumab, cemiplimab) significantly improves PFS & OS vs. chemo for PD-L1 ≥ 50%. Five-year OS reached 31.9% in key trials.
Read the full guideline: bit.ly/42PSX2U
#LungCancer
13
26
3,209
Our new living guideline Therapy for Stage IV NSCLC With Driver Alterations emphasizes broad NGS & IHC (PD-L1, HER2, MET) prior to frontline therapy. Comprehensive profiling is linked to ⬆️ OS & cost-effectiveness in Stage IV NSCLC: bit.ly/4wHjjSf
#LungCancer #NSCLC
7
18
6,005
ASCO retweeted
I feel very proud for having been selected to serve as a member of the International Quality Steering Group for the American Society of Clinical Oncology @ASCO starting today 3rd June 2026.
Inspired and committed to collaborate to raise the bar of cancer care delivery.
1
1
10
1,874